SPRO

0.742010.20%
TK

Timothy Keutzer

Chief Operating Officer

Mr. Timothy Keutzer, also known as Tim, serves as Chief Operating Officer of Spero Therapeutics, Inc. since February 01, 2023. He served as the Chief Development Officer of Spero Therapeutics, Inc. since June 2019 until February 01, 2023. Mr. Keutzer serves as Senior Vice President of Development at Spero Therapeutics, LLC. He served as Senior Vice President of Development at Spero Therapeutics, Inc. since September 2017 until June 2019. He has many years of experience in the pharmaceutical industry, spanning multiple functional and therapeutic areas. He served as Vice President of Development at Spero Therapeutics, Inc. from September 2015 to September 2017. Before joining Spero, he served as Vice President of Program and Portfolio Management at Cubist Pharmaceuticals. While there, he was the program leader for ceftolozane/tazobactam, which progressed rapidly from phase 1 to phase 3 clinical development and received market clearance by the U.S Food and Drug Administration in December 2014. He also led several of Cubist’s in-licensed development programs and also led the commercial supply chain for Cubicin. His experience before Cubist spans the drug development continuum across multiple drug classes and includes preclinical PK/PD and clinical operations at Genetics Institute, as well as global strategic marketing and program management at Wyeth. He began his career in contract toxicology labs. Mr. Keutzer earned his bachelor’s degree from the University of Kentucky.

Positions